Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HMBD-001 by Hummingbird Bioscience for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
HMBD-001 by Hummingbird Bioscience for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...
HMBD-001 by Hummingbird Bioscience for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
HMBD-001 by Hummingbird Bioscience for Gastric Cancer: Likelihood of Approval
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
HMBD-001 by Hummingbird Bioscience for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...